Infection News

Cystoscopies for recurrent UTIs yield little clinical benefit for patients both with and without high-risk features, according to a study.

SAN DIEGO — Pregnant patients who had more knowledge about COVID-19 and immunization were more likely to get vaccinated against SARS-CoV-2, according to a study presented here.

SAN DIEGO — In this video, Cynthia Gyamfi-Bannerman, MD, MS, FACOG, discusses the impact of SARS-CoV-2 on the pregnant population, which was the focus of her presentation at the ACOG Annual Clinical & Scientific Meeting.

SAN DIEGO — Passively self-collected menstrual blood for the detection of HPV showed results that were highly concordant with clinician-collected sampling and had greater acceptance among patients, researchers reported here.

SAN DIEGO — Results of a scoping review showed that home-based testing for sexually transmitted infections addresses important barriers that often prevent young people from seeking care, but few programs are tailored for youth.

Women with COVID-19 during pregnancy who subsequently received one mRNA vaccine dose had the highest levels of antibodies at delivery compared with infected, unvaccinated women and vaccinated women who were never infected.

The FDA has approved Vivjoa — the first medication for recurrent vulvovaginal candidiasis — for use in permanently infertile and postmenopausal women, according to a Mycovia Pharmaceuticals press release.

LISBON, Portugal — Pregnant women with SARS-CoV-2 infection passed antibodies to newborns in most cases, although there were no cases of neonatal infection in a study presented here.

Among people with a previous SARS-CoV-2 infection, women were more symptomatic than men — not just in the acute phase but also months later — according to a retrospective prospective study in the Journal of Women’s Health.

The years-long surge in STDs in the United States continued in 2020 during the first year of the COVID-19 pandemic, and there are indications that cases are still increasing, the CDC warned Tuesday.